A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy
Cells · 09.06.2026 · 15 (12) · 1056
DOI: 10.3390/cells15121056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 09.06.2026. Verfasst von Vitale Miceli und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Interleukin-1beta, Osteoarthritis, Mesenchymal Stem Cells, Adipose Tissue. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.
Abstract (Originalsprache)
Osteoarthritis is a chronic degenerative joint disease characterized by inflammation and cartilage degradation, for which current treatments are mainly symptomatic and unable to halt disease progression. Adipose-derived mesenchymal stem cells (ASCs) represent a promising therapeutic option due to their regenerative and immunomodulatory properties, which may be further enhanced through specific priming strategies. In this study, primary human ASCs were exposed to interleukin-1 beta (IL1β), interferon-gamma (IFNγ), or hypoxic priming, and subsequently analyzed using a multi-omics approach integrating RNA sequencing, proteomics of secretome, and exosomal miRNA profiling. Differential gene expression, protein abundance, and miRNA signatures were assessed together with functional enrichment and network analyses. IL1β priming induced marked transcriptional reprogramming of ASCs, while hypoxia and IFNγ priming produced limited changes. IL1β also profoundly reshaped the ASC secretome and exosomal miRNA cargo, revealing coordinated regulation of pathways involved in immune modulation and cartilage remodeling. In contrast, the other priming conditions showed minimal and less integrated molecular effects. Overall, IL1β priming consistently generated a multi-layered molecular signature linking immunoregulatory and regenerative pathways. These findings suggest that IL1β priming enhances the functional properties of ASCs and provides mechanistic insight supporting their potential use in osteoarthritis therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy.
- Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica (Di.Me.Pre-J), Università Degli Studi di Bari, Valenzano, 70124 Bari, Italy.
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi-Sant'Ambrogio Hospital, Via Cristina Belgioioso 173, 20157 Milan, Italy.
- Proteomics Group of Ri.MED Foundation, Research Department, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy.
- Plastic and Reconstructive Surgery and Breast Unit, La Maddalena Cancer Center, 90146 Palermo, Italy.
- Regenerative Medicine Division, Institute for Translational Research, Università della Svizzera Italiana (USI)-Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
ORCID-Profile: Vitale Miceli, Vincenzo Raffo, Silvia Lopa, Alessia Gallo, Nicola Cuscino, Simone Dario Scilabra, Margot Lo Pinto, Laura de Girolamo, Matteo Bulati, Alessandra Colombini
Förderung
- European Union
Zitieren
APA
Miceli, V., Ligotti, M. E., Raffo, V., Lopa, S., Ippolito, V., Gallo, A., Cuscino, N., Scilabra, S. D., Lo Pinto, M., Messina, S., D'Arpa, S., Moretti, M., de Girolamo, L., Bulati, M., & Colombini, A. (2026). A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy. Cells, 15(12), 1056. https://doi.org/10.3390/cells15121056
Vancouver
Miceli V, Ligotti ME, Raffo V, Lopa S, Ippolito V, Gallo A, et al. A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy. Cells. 2026;15(12):1056. doi:10.3390/cells15121056
BibTeX
@article{Miceli2026,
author = {Miceli, Vitale and Ligotti, Mattia Emanuela and Raffo, Vincenzo and Lopa, Silvia and Ippolito, Viviana and Gallo, Alessia and Cuscino, Nicola and Scilabra, Simone Dario and Lo Pinto, Margot and Messina, Simone and D'Arpa, Salvatore and Moretti, Matteo and de Girolamo, Laura and Bulati, Matteo and Colombini, Alessandra},
title = {A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy},
journal = {Cells},
year = {2026},
volume = {15},
number = {12},
pages = {1056},
doi = {10.3390/cells15121056}
}
EUVIMED